Dr. Dham has experience in stem cell transplantation, benign and malignant hematological disorders as well as tertiary oncology care. Her research activities include work on pulmonary embolism after transplant, and coagulation disorders in Antiphospholipid Syndrome. Dr. Dham’s work with renal cancer was presented at the American Society of Clinical Oncology Annual Meeting in 2007. Dr. Dham is a member of the American Society of Clinical Oncology and the American Society of Hematology.  In addition, Dr. Dham is a member of the Cancer Committee with Methodist Healthcare System.

Dr. Dham’s clinical interests include malignant hematological disorders and solid tumors, especially breast cancer, gastrointestinal and thoracic malignancies. In addition, she has a special interest in the many issues that are faced by cancer survivors.

Publications:

Sequential therapy with sorafenib and sunitinib in renal cell carcinoma. Cancer. 2008 Dec 2:115(1):61-67.

Sequential therapy with sorafenib and sunitinib in renal cell carcinoma.  Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings, Part I, Vol. 25, Vol. 18S (June 20 Supplement), 2007: 5106.

Dham A, Truskinovsky AM, Dudek, AZ.  Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report. J Thorac Oncol. 2008 Jan: 3(1):94-7.

Dham, A, Peterson, BA. Castleman disease. Curr Opin Hematol.  2007 Jul: 14(4):354-9.